These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 11796506)

  • 1. Structure-based design and synthesis of a thyroid hormone receptor (TR) antagonist.
    Baxter JD; Goede P; Apriletti JW; West BL; Feng W; Mellstrom K; Fletterick RJ; Wagner RL; Kushner PJ; Ribeiro RC; Webb P; Scanlan TS; Nilsson S
    Endocrinology; 2002 Feb; 143(2):517-24. PubMed ID: 11796506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid receptor ligands. 1. Agonist ligands selective for the thyroid receptor beta1.
    Ye L; Li YL; Mellström K; Mellin C; Bladh LG; Koehler K; Garg N; Garcia Collazo AM; Litten C; Husman B; Persson K; Ljunggren J; Grover G; Sleph PG; George R; Malm J
    J Med Chem; 2003 Apr; 46(9):1580-8. PubMed ID: 12699376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential sensitivity of thyroid hormone receptor isoform homodimers and mutant heterodimers to hormone-induced dissociation from deoxyribonucleic acid: its role in dominant negative action.
    Zhu XG; McPhie P; Cheng SY
    Endocrinology; 1997 Apr; 138(4):1456-63. PubMed ID: 9075702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the functional role of steroid receptor coactivator-1 in ligand-induced transactivation by thyroid hormone receptor.
    Jeyakumar M; Tanen MR; Bagchi MK
    Mol Endocrinol; 1997 Jun; 11(6):755-67. PubMed ID: 9171239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hammett analysis of selective thyroid hormone receptor modulators reveals structural and electronic requirements for hormone antagonists.
    Nguyen NH; Apriletti JW; Baxter JD; Scanlan TS
    J Am Chem Soc; 2005 Apr; 127(13):4599-608. PubMed ID: 15796525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. General receptor for phosphoinositides 1, a novel repressor of thyroid hormone receptor action that prevents deoxyribonucleic acid binding.
    Poirier MB; Hamann G; Domingue ME; Roy M; Bardati T; Langlois MF
    Mol Endocrinol; 2005 Aug; 19(8):1991-2005. PubMed ID: 15878955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
    Raval-Pandya M; Freedman LP; Li H; Christakos S
    Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterization and developmental expression patterns of thyroid hormone receptors (TRs) and their responsiveness to TR agonist and antagonist in Rana nigromaculata.
    Lou Q; Zhang Y; Ren D; Xu H; Zhao Y; Qin Z; Wei W
    J Environ Sci (China); 2014 Oct; 26(10):2084-94. PubMed ID: 25288553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoform variable action among thyroid hormone receptor mutants provides insight into pituitary resistance to thyroid hormone.
    Safer JD; Langlois MF; Cohen R; Monden T; John-Hope D; Madura J; Hollenberg AN; Wondisford FE
    Mol Endocrinol; 1997 Jan; 11(1):16-26. PubMed ID: 8994184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroxine-thyroid hormone receptor interactions.
    Sandler B; Webb P; Apriletti JW; Huber BR; Togashi M; Cunha Lima ST; Juric S; Nilsson S; Wagner R; Fletterick RJ; Baxter JD
    J Biol Chem; 2004 Dec; 279(53):55801-8. PubMed ID: 15466465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical role of glutamine 252 in the hormone-dependent transcriptional activity of the thyroid hormone beta1 nuclear receptor.
    Bhat MK; McPhie P; Cheng S
    Biochemistry; 1997 Apr; 36(14):4233-9. PubMed ID: 9100018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-terminal variants of thyroid hormone receptor beta: differential function and potential contribution to syndrome of resistance to thyroid hormone.
    Ng L; Forrest D; Haugen BR; Wood WM; Curran T
    Mol Endocrinol; 1995 Sep; 9(9):1202-13. PubMed ID: 7491112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid receptor ligands. 3. Design and synthesis of 3,5-dihalo-4-alkoxyphenylalkanoic acids as indirect antagonists of the thyroid hormone receptor.
    Hedfors A; Appelqvist T; Carlsson B; Bladh LG; Litten C; Agback P; Grynfarb M; Koehler KF; Malm J
    J Med Chem; 2005 May; 48(9):3114-7. PubMed ID: 15857115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of human beta 1 thyroid hormone receptor and its mutants with DNA and retinoid X receptor beta. T3 response element-dependent dominant negative potency.
    Meier CA; Parkison C; Chen A; Ashizawa K; Meier-Heusler SC; Muchmore P; Cheng SY; Weintraub BD
    J Clin Invest; 1993 Oct; 92(4):1986-93. PubMed ID: 8408652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of coactivator interaction can be a mechanism for dominant negative activity by mutant thyroid hormone receptors.
    Liu Y; Takeshita A; Misiti S; Chin WW; Yen PM
    Endocrinology; 1998 Oct; 139(10):4197-204. PubMed ID: 9751500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell type-dependent agonist/antagonist activities of polybrominated diphenyl ethers.
    Nakamura N; Matsubara K; Sanoh S; Ohta S; Uramaru N; Kitamura S; Yamaguchi M; Sugihara K; Fujimoto N
    Toxicol Lett; 2013 Nov; 223(2):192-7. PubMed ID: 24076165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinoid-X receptor (RXR) differentially augments thyroid hormone response in cell lines as a function of the response element and endogenous RXR content.
    Hsu JH; Zavacki AM; Harney JW; Brent GA
    Endocrinology; 1995 Feb; 136(2):421-30. PubMed ID: 7835272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amino acid substitutions of thyroid hormone receptor-beta at codon 435 with resistance to thyroid hormone selectively alter homodimer formation.
    Nomura Y; Nagaya T; Tsukaguchi H; Takamatsu J; Seo H
    Endocrinology; 1996 Oct; 137(10):4082-6. PubMed ID: 8828460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dominant negative inhibition by mutant thyroid hormone receptors is thyroid hormone response element and receptor isoform specific.
    Zavacki AM; Harney JW; Brent GA; Larsen PR
    Mol Endocrinol; 1993 Oct; 7(10):1319-30. PubMed ID: 8264663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid hormone antagonists: potential medical applications and structure activity relationships.
    Malm J; Färnegârdh M; Grover GJ; Ladenson PW
    Curr Med Chem; 2009; 16(25):3258-66. PubMed ID: 19548868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.